subject: Omeros Corporation (omer) - Financial And Strategic Analysis Review --- Aarkstore Enterprise [print this page] Omeros Corporation (OMER) - Financial and Strategic Analysis Review
Omeros Corporation (Omeros) is the US based clinical-stage bio-pharmaceutical company. It is engaged in the discovery, development and commercialization of products which are focused on inflammation and disorders of the central nervous system. The company's clinically advanced product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing ophthalmological, arthroscopic, urological and other surgical and medical procedures. It has four PharmacoSurgery programs which are in clinical development and has two other programs in preclinical development to treat inflammatory disorders.
Omeros Corporation Key Recent Developments
May 13, 2010: Omeros Selects Clinical Candidate For MASP-2 Program With Potential Applicability To Multiple Inflammatory Disorders
May 12, 2010: Omeros Reports Net Loss Of $6.7 Million For Q1 2010
Mar 10, 2010: Omeros Secures Exclusive License To PDE7 Compounds For Parkinson Disease Program
Jan 28, 2010: Omeros Announces National Institute On Drug Abuse's Support For Phase II Clinical Study In Addiction Program
This comprehensive SWOT profile of Omeros Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Omeros Corporation, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
